Home
Accord Healthcare, Inc.

七月 2026的Accord Healthcare, Inc.市场份额分析

Accord Healthcare is a global provider of generic and specialty pharmaceuticals. Our focus on a rapidly expanding portfolio of affordable generic

健康 > 药房

域accordhealthcare.us

成立年份1976

员工201 - 500

年营收--

Accord Healthcare, Inc.

Accord Healthcare, Inc.（包含公司地区分支机构）

accordhealthcare.us

查看更多网站流量和参与度信息

Accord Healthcare, Inc.热门域名的总访问量

了解Accord Healthcare, Inc.市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

accordhealthcare.us6.1K

使用销售情报查看更多信息

Accord Healthcare, Inc.热门域名的平均访问时长

分析Accord Healthcare, Inc.参与度指标。

过去 3 个月的平均访问时长

子公司明细

accordhealthcare.us00:00:27

使用销售情报查看更多信息

Accord Healthcare, Inc.热门域名的平均页面浏览量

了解Accord Healthcare, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

accordhealthcare.us1.97

使用销售情报查看更多信息

Accord Healthcare, Inc. 排名靠前的竞争对手（按域名）

似乎没有足够的数据。

无数据可显示

Accord Healthcare, Inc. 采用的主要技术

这些是排名前 Accord Healthcare, Inc. 的顶级域名所使用的网站技术（按行业分列）

小部件 (6)

Twemoji

付费广告 (2)

Google Adsense

内容管理系统 (2)

WordPress

移动设备 (2)

Meta Viewport

更多技术

4

查看全部

Accord Healthcare, Inc. 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Accord Healthcare, Inc. launched Sugammadex Injection on Aug 5th '26.RALEIGH, N.C., Aug. 5, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the launch of Sugammadex Injection, indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.

新闻Accord Healthcare Inc launched Tadalafil Tablets on May 4th '26.RALEIGH, N.C., May 4, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the relaunch of Tadalafil Tablets, an FDA-approved phosphodiesterase type 5 (PDE5) inhibitor for oral administration, available in multiple dosage strengths.

新闻Accord Healthcare Inc launched Lenalidomide Capsules on Feb 17th '26.RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading U.S. pharmaceutical company, today announced the launch of Lenalidomide Capsules in the United States, reinforcing the company's commitment to expanding access to high-quality, affordable oncology therapies for patients.